2021 Health Equity and Inclusiveness Research Fellow Award Eduardo Nunez, MD Boston University School of Medicine Boston MA Research Summary Lung cancer is the leading cause of cancer death worldwide and screening has the potential to reduce lung cancer mortality by approximately 20%. However, how to optimize adherence to lung cancer screening in real-world populations with diverse backgrounds and barriers to access remains unknown. Our study proposes to identify patient, provider, facility, and community-level barriers to screening adherence, as well as factors that promote adherence in three distinct cancer screening programs and communities. After identifying these critical and modifiable factors, we will engage local stakeholders and deliver a tailored implementation plan to improve adherence to lung cancer screening overall and among underserved and marginalized populations. Technical Abstract Lung cancer remains the leading cause of cancer death worldwide and clinical trials show that annual lung cancer screening with low-dose Computed Tomography can reduce lung cancer-related mortality by 20%. Marginalized populations are disproportionately affected by lung cancer and our prior work has shown that these disparities extend to lung cancer screening; in a national cohort of Veterans we found that Black Veterans, those with mental health disorders and lower income were less likely to adhere to lung cancer screening follow-up recommendations. Currently, little is known about how to optimize lung cancer screening in underserved populations and marginalized populations from diverse backgrounds. This proposed project focuses on identifying barriers and facilitators to lung cancer screening at the patient, provider, facility and community-levels. We plan to use mixed methods to quantitatively explore factors associated with delayed or lack of adherence to lung cancer screening and then perform in-depth qualitative analysis to identify which factors are critical and modifiable. We will use an implementation strategy mapping tool to select evidence-based strategies best suited to address the identified barriers and develop a tailored implementation plan to improve adherence to lung cancer screening, both overall and among underserved populations, at Baystate Health System. This work is critical in achieving equity in lung cancer screening and improving overall lung cancer mortality among patients. Key words Early detection Health equity Non-small cell lung cancer (NSCLC) Screening Stage I Stage II Veterans Affairs